On October 7, GNYHA will host a webinar on the final United States Pharmacopeia (USP) <795>, <797>, and <800> Standards and The Joint Commission’s (TJC) updated hospital accreditation program requirements to reduce risks associated with sterile medication compounding and hazardous drug handling.

Robert Campbell, PharmD, Director, Clinical Standards Interpretation Hospital/Ambulatory Programs Director, Medication Management, at TJC, will review the enhanced sterile medication compounding and hazardous drug management evaluation that TJC will emphasize on hospital accreditation surveys. Other topics of discussion will include national trends on organizational compliance with TJC standards and recommendations to assist health systems with their compliance efforts.